Fundz

Topadur Pharma AG Appoints Matthias Schäfer as Chief Executive Officer

PRIVATEDec 17, 2025

Position

Chief Executive Officer

Company

Topadur Pharma AG

Matthias Schäfer
ZurichBiotechnologyHealth CareTherapeutics

Description

Topadur Pharma AG has appointed PD Dr. Matthias Schäfer as Chief Executive Officer as the company enters a new phase of clinical advancement. Dr

Quick answer

Topadur Pharma AG Appoints Matthias Schäfer as Chief Executive Officer (December 17, 2025). Topadur Pharma AG is based in Zurich, Zurich, Switzerland.

Who is the new Chief Executive Officer at Topadur Pharma AG?
Topadur Pharma AG named Matthias Schäfer Chief Executive Officer, announced December 17, 2025.
What did Topadur Pharma AG announce on December 17, 2025?
Topadur Pharma AG has appointed PD Dr. Matthias Schäfer as Chief Executive Officer as the company enters a new phase of clinical advancement.
What does Topadur Pharma AG do?
Topadur Pharma AG is a clinical-stage biotechnology company focused on developing innovative therapies for vascular regeneration.
Where is Topadur Pharma AG based?
Topadur Pharma AG is based in Zurich, Zurich, Switzerland.
Which similar companies made leadership changes around the same time?
Pliant Therapeutics (December 16, 2025), Gilead Sciences (December 18, 2025), Silence Therapeutics plc (December 15, 2025) and Centessa Pharmaceuticals plc (December 12, 2025) also announced leadership changes within 45 days of Topadur Pharma AG.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Topadur Pharma AG, and when

A new leader at Topadur Pharma AG brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Topadur Pharma AG raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Topadur Pharma AG, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Topadur Pharma AG. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Topadur Pharma AG

Location

Zurich, Zurich, Switzerland

About

Topadur Pharma AG is a clinical-stage biotechnology company focused on developing innovative therapies for vascular regeneration. The company is advancing its clinical programs toward strategic milestones. It aims to address significant unmet clinical needs in areas like systemic sclerosis and diabetic foot ulcers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Topadur Pharma AG changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Topadur Pharma AG's next move

Learn about Strategic plan

Topadur Pharma AG changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.